Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer. - Wikidata - awgldk - TriplyDB

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

http://www.wikidata.org/entity/Q37727746

about

Apoptotic and Immune Restoration Effects of Ganoderic Acids Define a New Prospective for Complementary Treatment of Cancer Ganoderic Acid in the treatment of prostate cancer.Anticancer Activity of Ganoderic Acid DM: Current Status and Future Perspective.

P2860

Q36537850-FE18B962-C5BA-46FF-AA20-675216B5BD85 Q41996829-FEB04A2E-43CE-48C8-A8D2-32D46CDE6486 Q49333655-3EEC3BBA-EC36-4DBF-8103-C3008C8A91D5

P2860

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

http://www.wikidata.org/entity/Q37727746

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

@en

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

@nl

type

label

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

@en

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

@nl

prefLabel

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

@en

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

@nl

P1433

Q37727746-2C0DB28E-705A-4B4E-9DA8-6A5BF5450C27

P1476

Q37727746-748698EF-A672-4A0D-B847-5684F6615AE5

P2093

Q37727746-5CD25618-CB8F-40F8-AFF2-BDBEE8C93996

Q37727746-8CE24659-43CE-44B3-86A3-D6A5478C0D57

Q37727746-CB98CEC0-DBC6-45A9-AA08-5ECF3D1C30A6

Q37727746-D54DA215-2233-4593-BBCB-B7529682316C

P2860

Q37727746-00B4607E-8CA0-451D-8D34-9DD0FBD6C9B0

Q37727746-19676D63-807E-4433-9DF8-462E4452AEBE

Q37727746-2A0EC695-1E4D-4488-95FC-5EE9C9E21496

Q37727746-32E3F269-501A-49AD-BC4A-9DB0C41F66F6

Q37727746-35897C6D-928F-4D2E-A185-464F9751266A

Q37727746-35BB0879-0BCB-45EC-B3F7-5B2527F01DB3

Q37727746-37F7B5EE-F651-4FCF-B2B3-08AED6868DE4

Q37727746-3FA767C7-E009-439E-86B9-1C6E35C22C24

Q37727746-44ED2185-DD09-4ACB-AD05-CAED78A9408D

Q37727746-46E7808A-77C7-48DB-85F1-9B42B6ACAC34

P304

Q37727746-0067EAA6-48A8-4E56-84D2-42B5D4943C0E

P31

Q37727746-C49DD776-345A-40BF-B818-BC85F335F8BB

P356

Q37727746-26F5BF19-1349-4E93-9EF1-5D3973634F0D

P478

Q37727746-F7F20D0A-EB09-424A-B1B0-7D3C81D306ED

P577

Q37727746-FE3AA796-517D-4DEB-BD29-6F78144AE8D9

P698

Q37727746-D8B50021-1285-4880-9353-138CD50E8B6D

P932

Q37727746-FB075AFE-E824-4085-A0CB-FA5D1E97E433

P356

1876822901003010078

P1433

The open prostate cancer journal

P1476

Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

@en

P2093

Azizul Haque

http://www.w3.org/2001/XMLSchema#string

Benjamin M Johnson

http://www.w3.org/2001/XMLSchema#string

Bently P Doonan

http://www.w3.org/2001/XMLSchema#string

Faisal F Radwan

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoclasts are active in bone forming metastases of prostate cancer patients

Anticancer Effects of Ganoderma lucidum: A Review of Scientific Evidence

Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum

Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo

Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1.

Androgens and the male reproductive tract: an overview of classical roles and current perspectives.

Therapeutic vaccines for prostate cancer: a review of clinical data.

Targeted delivery of multifunctional magnetic nanoparticles.

Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging.

Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?

P304

78-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1876822901003010078

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24790681

http://www.w3.org/2001/XMLSchema#string

P932

4002166

http://www.w3.org/2001/XMLSchema#string